Dr. Kurhanewicz came to UCSF, and stayed for so many years, because it allows him to do basic research, but also work very closely with clinical colleagues to get his work into the clinics, which he calls the translation process. He has seen two techniques go from the benchtop to patients. In one setting, they took the MRI exam for prostate cancer and improved it by adding additional parameters. They added metabolism to anatomic imaging and produced, with GE Healthcare, the first patient exam and took it into the first phase 1 clinical trial. Now, they are doing it again.